Tens of thousands of Kaiser Permanente workers in California and Hawaii have gone on strike, demanding safer staffing levels and higher pay. The dispute underscores growing tensions in healthcare ...
Insurers are cutting coverage for costly GLP-1 weight loss drugs, sparking backlash from advocates who say they're vital for ...
Experts warn that the Trump administration’s new $100,000 fee for H-1B visa applications could worsen healthcare’s workforce ...
Novo Nordisk is paying $240 million up front for global rights to zaltenibart, an Omeros drug that blocks the MASP-3 protein to treat diseases caused by excessive activity of the complement system.
Novo Nordisk is acquiring Akero Therapeutics for drug candidate efruxifermin, which executive say could be first and best in ...
Kailera Therapeutics executives say their lead drug candidate could become best in a category of obesity drugs currently led by a blockbuster Eli Lilly product, and the biotech has secured $600 ...
Interoperability doesn’t start with a 9-1-1 call. It begins with a commitment to data quality, documentation integrity, and adherence to national standards across the system. For EMS, this means ...
Knowing your customer is the first rule of business. The rising tide of consumerism in the healthcare industry means that more attention is being paid to define the consumer or the end customer. Based ...
Digital health funding is holding steady — venture capital is flowing, IPOs are reappearing, and megarounds are back in force. Startups in this space have raised $9.9 billion throughout the first ...
Talkspace, a virtual mental health company, announced on Monday that it has acquired Wisdo Health, a platform for social health and peer support. New York City-based Talkspace offers virtual therapy, ...
CertifyOS, a provider data intelligence company, has launched a new platform to help payers manage provider data in their network, the company announced last week. New York City-based CertifyOS serves ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results